BlackRock Fund Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$27.8M Buy
1,360,818
+696,072
+105% +$14.2M 0.01% 1995
2016
Q3
$9.97M Buy
664,746
+42,183
+7% +$633K ﹤0.01% 2474
2016
Q2
$6.74M Buy
622,563
+355,957
+134% +$3.85M ﹤0.01% 2633
2016
Q1
$3.62M Sell
266,606
-14,348
-5% -$195K ﹤0.01% 2904
2015
Q4
$5.18M Buy
280,954
+15,241
+6% +$281K ﹤0.01% 2823
2015
Q3
$6.73M Buy
+265,713
New +$6.73M ﹤0.01% 2608